Finance News – Zepbound

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Stocks Shares Tariffs Stock Investors Ceo Stock Market Crypto Assets Ethereum Cryptocurrency Price Markets Xrp Eth Etf Bse Earnings Ipo Stablecoin Investment Blockchain Revenue Solana Index Trade Sec Inflation Interest Rates Token Wall Street Coinbase Sensex Treasury Federal Reserve Nasdaq Profit Traders Nse China Bse Sensex Sp 500 Nifty Investor Gold Tesla Company Economy Aurum Resources Banco Products Macro Factors User Accounts Alvotech Texas Lawmakers Reservation Rates Multicap Fund Dapp Development Bank Balance

Filter by:

Zepbound ×

MarketWatch Top Stories • Aug 02, 2025

Weight-loss drugs may be covered by Medicare, Medicaid under experimental program

The experimental program could potentially reduce out-of-pocket expenses for patients by allowing Medicare and Medicaid to cover expensive GLP-1 medications used for weight managem...

Read Full Article →

Quartz • May 12, 2025

Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

The superior results of Eli Lilly’s medication compared to Novo Nordisk’s in the recent trial may influence market dynamics and investor confidence within the competitive obesity t...

Read Full Article →

CNBC Business • May 01, 2025

Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer...

Eli Lilly experienced a significant increase in sales attributed to strong demand for its weight loss and diabetes medications, yet adjusted its profit forecast following a recent...

Read Full Article →